Found: 16
Select item for more details and to access through your institution.
Lymphocyte dysfunction in cartilage hair hypoplasia. II. Evidence for a cell cycle specific defect in T cell growth.
- Published in:
- Clinical & Experimental Immunology, 1982, v. 49, n. 3, p. 621
- By:
- Publication type:
- Article
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
- Published in:
- 1989
- By:
- Publication type:
- journal article
A portable beam for mounting intensive care devices.
- Published in:
- Anaesthesia, 1976, v. 31, n. 1, p. 78, doi. 10.1111/j.1365-2044.1976.tb11751.x
- By:
- Publication type:
- Article
What is a cure and how do we get there?
- Published in:
- Haemophilia, 2004, v. 10, p. 115, doi. 10.1111/j.1365-2516.2004.00999.x
- By:
- Publication type:
- Article
Gene therapy: reality or myth for the global bleeding disorders community?
- Published in:
- Haemophilia, 2002, v. 8, n. 3, p. 261, doi. 10.1046/j.1365-2516.2002.00646.x
- By:
- Publication type:
- Article
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.
- Published in:
- Haemophilia, 2018, v. 24, n. 4, p. e167, doi. 10.1111/hae.13504
- By:
- Publication type:
- Article
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes.
- Published in:
- Haemophilia, 2018, v. 24, p. 60, doi. 10.1111/hae.13489
- By:
- Publication type:
- Article
Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.
- Published in:
- Haemophilia, 2018, v. 24, p. 87, doi. 10.1111/hae.13506
- By:
- Publication type:
- Article
World bleeding disorders registry: The pilot study.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
First‐year results of an expanded humanitarian aid programme for haemophilia in resource‐constrained countries.
- Published in:
- Haemophilia, 2018, v. 24, n. 2, p. 229, doi. 10.1111/hae.13409
- By:
- Publication type:
- Article
Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A- LONG study subjects with severe haemophilia A.
- Published in:
- Haemophilia, 2017, v. 23, p. 392, doi. 10.1111/hae.13144
- By:
- Publication type:
- Article
Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A- LONG and B- LONG clinical studies.
- Published in:
- Haemophilia, 2016, v. 22, n. 6, p. 866, doi. 10.1111/hae.12987
- By:
- Publication type:
- Article
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. 72, doi. 10.1111/hae.12766
- By:
- Publication type:
- Article
Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein.
- Published in:
- Haemophilia, 2014, v. 20, n. 4, p. e327, doi. 10.1111/hae.12451
- By:
- Publication type:
- Article
Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.
- Published in:
- Haemophilia, 2014, v. 20, n. 2, p. 294, doi. 10.1111/hae.12296
- By:
- Publication type:
- Article